Harbin Medisan Pharmaceutical Co Ltd Financial Flexibility Index
Harbin Medisan Pharmaceutical Co Ltd financial flexibility index. Harbin Medisan Pharmaceutical Co Ltd (002900) has a Financial Flexibility Index of 0.01x as of September 2025. Free cash flow of CN¥13.63 Million (operating CF CN¥-15.53 Million minus capex CN¥29.16 Million) represents 0% of total liabilities (CN¥1.70 Billion). Explore Harbin Medisan Pharmaceutical Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Harbin Medisan Pharmaceutical Co Ltd (2012–2024)
Financial flexibility index of Harbin Medisan Pharmaceutical Co Ltd from 2012 to 2024. Historical Financial Flexibility Index trend for Harbin Medisan Pharmaceutical Co Ltd across 13 annual periods. Check Harbin Medisan Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Harbin Medisan Pharmaceutical Co Ltd Financial Flexibility Index by Year (2012–2024)
Harbin Medisan Pharmaceutical Co Ltd financial flexibility index by year from 2012 to 2024. Year-by-year free cash flow to debt coverage for Harbin Medisan Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Harbin Medisan Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.23x | CN¥376.89 Million | CN¥30.69 Million | CN¥1.64 Billion | ▼ -11.1% |
| 2023 | 0.26x | CN¥335.27 Million | CN¥35.69 Million | CN¥1.29 Billion | ▲ +35.6% |
| 2022 | 0.19x | CN¥233.87 Million | CN¥144.64 Million | CN¥1.22 Billion | ▲ +195.1% |
| 2021 | 0.06x | CN¥61.42 Million | CN¥-12.53 Million | CN¥949.04 Million | ▼ -68.4% |
| 2020 | 0.20x | CN¥141.35 Million | CN¥-4.51 Million | CN¥691.18 Million | ▼ -67.7% |
| 2019 | 0.63x | CN¥518.77 Million | CN¥320.14 Million | CN¥820.44 Million | ▼ -7.3% |
| 2018 | 0.68x | CN¥370.87 Million | CN¥292.46 Million | CN¥543.78 Million | ▼ -27.6% |
| 2017 | 0.94x | CN¥328.39 Million | CN¥223.46 Million | CN¥348.80 Million | ▲ +3.7% |
| 2016 | 0.91x | CN¥325.06 Million | CN¥231.18 Million | CN¥358.01 Million | ▼ -13.9% |
| 2015 | 1.05x | CN¥342.57 Million | CN¥200.85 Million | CN¥324.95 Million | ▲ +45.3% |
| 2014 | 0.73x | CN¥262.12 Million | CN¥116.31 Million | CN¥361.30 Million | ▲ +11.3% |
| 2013 | 0.65x | CN¥321.22 Million | CN¥167.10 Million | CN¥492.63 Million | ▲ +14.5% |
| 2012 | 0.57x | CN¥214.23 Million | CN¥123.22 Million | CN¥376.29 Million | — |